UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Clinical transplantation, 2019-09, Vol.33 (9), p.e13548-n/a

2019

Volltextzugriff (PDF)

Epidemiology of Methicillin-Resistant Staphylococcus aureus

Clinical infectious diseases, 2008-06, Vol.46 (Supplement-5), p.S344-S349

2008

Volltextzugriff (PDF)

Partial Oral Therapy for Osteomyelitis and Endocarditis — Is It Time?

The New England journal of medicine, 2019-01, Vol.380 (5), p.487-489

Boucher, Helen W

2019

Volltextzugriff (PDF)

New Antibiotics for Resistant Infections: What Happens After Approval?

Annals of internal medicine, 2024-05, Vol.177 (5), p.674-675

2024

Volltextzugriff (PDF)

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Clinical infectious diseases, 2009-01, Vol.48 (1), p.1-12

2009

Volltextzugriff (PDF)

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

CA: a cancer journal for clinicians, 2021-11, Vol.71 (6), p.488-504

2021

Volltextzugriff (PDF)

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

Clinical infectious diseases, 2020-04, Vol.70 (9), p.1799-1808

2020

Volltextzugriff (PDF)

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

The New England journal of medicine, 2014-06, Vol.370 (23), p.2169-2179

2014

Volltextzugriff (PDF)

Social class and self-concept consistency: Implications for subjective well-being and felt authenticity

Self and identity, 2021-04, Vol.20 (3), p.406-422

Boucher, Helen C.

2021

Volltextzugriff (PDF)

Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci

Mayo Clinic proceedings, 2011-12, Vol.86 (12), p.1230-1243

2011

Volltextzugriff (PDF)

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4539-e4548

2021

Volltextzugriff (PDF)

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1685-1694

2013

Volltextzugriff (PDF)

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1685-1694

2013

Volltextzugriff (PDF)

The Dialectical Self-Concept II: Cross-Role and Within-Role Consistency, Well-Being, Self-Certainty, and Authenticity

Journal of cross-cultural psychology, 2011-10, Vol.42 (7), p.1251-1271

Boucher, Helen C.

2011

Volltextzugriff (PDF)

The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?

Clinical infectious diseases, 2019-06, Vol.69 (1), p.1-11

2019

Volltextzugriff (PDF)

Respiratory Tract Infections in the Postpandemic Era: A Return to Basics and Call to Action

Infectious disease clinics of North America, 2024-03, Vol.38 (1), p.xiii-xv

2024

Volltextzugriff (PDF)

U.S. Efforts to Curb Antibiotic Resistance — Are We Saving Lives?

The New England journal of medicine, 2020-08, Vol.383 (9), p.806-808

2020

Volltextzugriff (PDF)

Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1120-1129

2019

Volltextzugriff (PDF)

Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus

Clinical infectious diseases, 2007-09, Vol.45 (5), p.601-608

2007

Volltextzugriff (PDF)

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives

Clinical infectious diseases, 2011-05, Vol.52 (suppl_5), p.S397-S428

2011

Volltextzugriff (PDF)

Dalbavancin for the treatment of acute bacterial skin and skin structure infections

Expert opinion on pharmacotherapy, 2015-09, Vol.16 (13), p.2073-2081

2015

Volltextzugriff (PDF)

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

Clinical infectious diseases, 2008-01, Vol.46 (2), p.155-164

2008

Volltextzugriff (PDF)

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Clinical infectious diseases, 2024-02, Vol.78 (2), p.259-268

2024

Volltextzugriff (PDF)

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial

Clinical infectious diseases, 2023-01, Vol.76 (1), p.66-77

2023

Volltextzugriff (PDF)

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Antimicrobial agents and chemotherapy, 2024-07, Vol.68 (7)

2024

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(217)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(244)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(136)
Humans
(103)
Infectious Diseases
(76)
Microbiology
(72)
Immunology
(54)
Anti-Bacterial Agents - Therapeutic Use
(43)
Biological And Medical Sciences
(42)
Female
(37)
Medical Sciences
(36)
Male
(35)
Antibiotics
(30)
Pharmacology & Pharmacy
(28)
Anti-Bacterial Agents - Pharmacology
(26)
Adult
(23)
Clinical Trials
(23)
Staphylococcus Aureus
(23)
Infections
(21)
Social Sciences
(20)
Middle Aged
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Epidemiology of Methicillin-Resistant Staphylococcus aureus

Partial Oral Therapy for Osteomyelitis and Endocarditis — Is It Time?

New Antibiotics for Resistant Infections: What Happens After Approval?

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

Social class and self-concept consistency: Implications for subjective well-being and felt authenticity

Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

The Dialectical Self-Concept II: Cross-Role and Within-Role Consistency, Well-Being, Self-Certainty, and Authenticity

The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?

Respiratory Tract Infections in the Postpandemic Era: A Return to Basics and Call to Action

U.S. Efforts to Curb Antibiotic Resistance — Are We Saving Lives?

Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis

Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives

Dalbavancin for the treatment of acute bacterial skin and skin structure infections

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Suchergebnisse filtern